In addition to 17p deletion involving TP53, other tumor suppressors such as RB1, PTEN and CDKN1B have been reported, along with amplification of STAT3 (17q) and MYC (8q) (23–25, 65–67). The gene discussed is TP53; the disease is neoplasm.